Question follow-through · 38167
Medicines and Healthcare products Regulatory Agency and National Institute for Health and Care Research
To ask the Secretary of State for Health and Social Care, whether his Department has plans to take steps to streamline approvals processes for the (a) Medicines and Healthcare products Regulatory Agency and (ii) National Institute for Health and Care Rese
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 13 Mar 2025
- Target answer date
- 17 Mar 2025
- Answer
- 19 Mar 2025 · 6 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Coronavirus: Screening · 22 Jul 2025
- Coronavirus: Disease Control · 22 Jul 2025
- Disease Control: Departmental Responsibilities · 13 Oct 2025
- Disease Control · 18 Nov 2025
- Disease Control · 18 Nov 2025
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
13 Mar 2025
Question tabled
To ask the Secretary of State for Health and Social Care, whether his Department has plans to take steps to streamline approvals processes for the (a) Medicines and Healthcare products Regulatory Agency and (ii) National Institute for Health and Care Rese
17 Mar 2025
Target answer date
Date supplied by the official written-questions record.
19 Mar 2025
Answer published
The Medicines and Healthcare products Regulatory Agency (MHRA) continues to optimise its performance in delivering efficient and predictable services which meet stakeholders’ expectations, for the benefit of patients and public health and the Life Science...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Coronavirus: Screening
22 Jul 2025 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of changes to National Institute for Health and Care Excellence guidance in May 2025 on supporting patients in accessing lateral flow tests for c
Coronavirus: Disease Control
22 Jul 2025 · To ask the Secretary of State for Health and Social Care, how many Integrated Care Boards in England provide Covid Medicines Delivery Units.
Disease Control: Departmental Responsibilities
13 Oct 2025 · To ask the Secretary of State for Health and Social Care, which Minister is responsible for vulnerable groups and pandemics.
Disease Control
18 Nov 2025 · To ask the Secretary of State for Health and Social Care, when his Department will publish the report findings from Exercise Pegasus.
Disease Control
18 Nov 2025 · To ask the Secretary of State for Health and Social Care, which minister will be responsible for implementing the findings from Exercise Pegasus.
Disease Control
18 Nov 2025 · To ask the Secretary of State for Health and Social Care, what timeframes his Department will set out to implement the findings of Exercise Pegasus.
Disease Control
18 Nov 2025 · To ask the Secretary of State for Health and Social Care, whether Exercise Pegasus involved consultation with clinically vulnerable patient groups.
Disease Control
18 Nov 2025 · To ask the Secretary of State for Health and Social Care, which health bodies from England, Wales, Scotland and Northern Ireland were involved in Exercise Pegasus.
Disease Control: Immunosuppression
18 Nov 2025 · To ask the Secretary of State for Health and Social Care, what engagement did Exercise Pegasus have with pharmaceutical providers on the procurement of pre-prophylactic drugs for immunocompromised patients.
Disease Control
18 Nov 2025 · To ask the Secretary of State for Health and Social Care, what engagement did Exercise Pegasus have with pharmaceutical providers on the procurement of vaccinations.
Disease Control: Immunosuppression
18 Nov 2025 · To ask the Secretary of State for Health and Social Care, what engagement did Exercise Pegasus have with providers in the procurement of adequate Personal Protective Equipment for immunocompromised patients.
Migraines
20 Apr 2026 · To ask the Secretary of State for Health and Social Care, whether his department has plans to strengthen national policy recognition of migraine as a serious neurological condition.